Journal article 1960 views
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
N. R Melo,
G. P Moran,
Andrew Warrilow 
,
Ed Dudley,
S. N Smith,
D. J Sullivan,
D. C Lamb,
Diane Kelly,
D. C Coleman,
Steven Kelly
,
Ed Dudley,
S. N Smith,
D. J Sullivan,
D. C Lamb,
Diane Kelly,
D. C Coleman,
Steven Kelly
Antimicrobial Agents and Chemotherapy, Volume: 52, Issue: 10, Pages: 3718 - 3724
Swansea University Authors:
Andrew Warrilow , Ed Dudley, Diane Kelly, Steven Kelly
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1128/AAC.00446-08
Abstract
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility
| Published in: | Antimicrobial Agents and Chemotherapy |
|---|---|
| ISSN: | 0066-4804 1098-6596 |
| Published: |
2008
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa6349 |
| first_indexed |
2013-07-23T11:54:33Z |
|---|---|
| last_indexed |
2021-10-27T02:17:53Z |
| id |
cronfa6349 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-10-26T14:13:18.0072660</datestamp><bib-version>v2</bib-version><id>6349</id><entry>2011-10-01</entry><title>CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility</title><swanseaauthors><author><sid>f066e233e8d0136c9f547b86fa43747f</sid><ORCID>0000-0003-0183-8334</ORCID><firstname>Andrew</firstname><surname>Warrilow</surname><name>Andrew Warrilow</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>c7d05f992a817cd3b9a5f946bd909b71</sid><firstname>Ed</firstname><surname>Dudley</surname><name>Ed Dudley</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5ccf81e5d5beedf32ef8d7c3d7ac6c8c</sid><firstname>Diane</firstname><surname>Kelly</surname><name>Diane Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b17cebaf09b4d737b9378a3581e3de93</sid><firstname>Steven</firstname><surname>Kelly</surname><name>Steven Kelly</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2011-10-01</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Antimicrobial Agents and Chemotherapy</journal><volume>52</volume><journalNumber>10</journalNumber><paginationStart>3718</paginationStart><paginationEnd>3724</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0066-4804</issnPrint><issnElectronic>1098-6596</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2008</publishedYear><publishedDate>2008-12-31</publishedDate><doi>10.1128/AAC.00446-08</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-10-26T14:13:18.0072660</lastEdited><Created>2011-10-01T00:00:00.0000000</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>N. R</firstname><surname>Melo</surname><order>1</order></author><author><firstname>G. P</firstname><surname>Moran</surname><order>2</order></author><author><firstname>Andrew</firstname><surname>Warrilow</surname><orcid>0000-0003-0183-8334</orcid><order>3</order></author><author><firstname>Ed</firstname><surname>Dudley</surname><order>4</order></author><author><firstname>S. N</firstname><surname>Smith</surname><order>5</order></author><author><firstname>D. J</firstname><surname>Sullivan</surname><order>6</order></author><author><firstname>D. C</firstname><surname>Lamb</surname><order>7</order></author><author><firstname>Diane</firstname><surname>Kelly</surname><order>8</order></author><author><firstname>D. C</firstname><surname>Coleman</surname><order>9</order></author><author><firstname>Steven</firstname><surname>Kelly</surname><order>10</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2021-10-26T14:13:18.0072660 v2 6349 2011-10-01 CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility f066e233e8d0136c9f547b86fa43747f 0000-0003-0183-8334 Andrew Warrilow Andrew Warrilow true false c7d05f992a817cd3b9a5f946bd909b71 Ed Dudley Ed Dudley true false 5ccf81e5d5beedf32ef8d7c3d7ac6c8c Diane Kelly Diane Kelly true false b17cebaf09b4d737b9378a3581e3de93 Steven Kelly Steven Kelly true false 2011-10-01 MEDS Journal Article Antimicrobial Agents and Chemotherapy 52 10 3718 3724 0066-4804 1098-6596 31 12 2008 2008-12-31 10.1128/AAC.00446-08 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2021-10-26T14:13:18.0072660 2011-10-01T00:00:00.0000000 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine N. R Melo 1 G. P Moran 2 Andrew Warrilow 0000-0003-0183-8334 3 Ed Dudley 4 S. N Smith 5 D. J Sullivan 6 D. C Lamb 7 Diane Kelly 8 D. C Coleman 9 Steven Kelly 10 |
| title |
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility |
| spellingShingle |
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility Andrew Warrilow Ed Dudley Diane Kelly Steven Kelly |
| title_short |
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility |
| title_full |
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility |
| title_fullStr |
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility |
| title_full_unstemmed |
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility |
| title_sort |
CYP56 (Dit2p) in Candida albicans: Characterization and Investigation of Its Role in Growth and Antifungal Drug Susceptibility |
| author_id_str_mv |
f066e233e8d0136c9f547b86fa43747f c7d05f992a817cd3b9a5f946bd909b71 5ccf81e5d5beedf32ef8d7c3d7ac6c8c b17cebaf09b4d737b9378a3581e3de93 |
| author_id_fullname_str_mv |
f066e233e8d0136c9f547b86fa43747f_***_Andrew Warrilow c7d05f992a817cd3b9a5f946bd909b71_***_Ed Dudley 5ccf81e5d5beedf32ef8d7c3d7ac6c8c_***_Diane Kelly b17cebaf09b4d737b9378a3581e3de93_***_Steven Kelly |
| author |
Andrew Warrilow Ed Dudley Diane Kelly Steven Kelly |
| author2 |
N. R Melo G. P Moran Andrew Warrilow Ed Dudley S. N Smith D. J Sullivan D. C Lamb Diane Kelly D. C Coleman Steven Kelly |
| format |
Journal article |
| container_title |
Antimicrobial Agents and Chemotherapy |
| container_volume |
52 |
| container_issue |
10 |
| container_start_page |
3718 |
| publishDate |
2008 |
| institution |
Swansea University |
| issn |
0066-4804 1098-6596 |
| doi_str_mv |
10.1128/AAC.00446-08 |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2008-12-31T03:10:26Z |
| _version_ |
1851451586888335360 |
| score |
11.089572 |